Sabra Health Care REIT Receives New Coverage from Analysts at MLV & Co (SBRA)
Research analysts at MLV & Co
began coverage on shares of Sabra Health Care REIT (NASDAQ:SBRA) in a report released on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $31.00 price target on the stock. MLV & Co
‘s target price points to a potential upside of 9.66% from the stock’s previous close.
Shares of Sabra Health Care REIT (NASDAQ:SBRA) traded up 0.60% on Friday, hitting $28.44. The stock had a trading volume of 104,244 shares. Sabra Health Care REIT has a one year low of $21.55 and a one year high of $31.17. The stock has a 50-day moving average of $28.67 and a 200-day moving average of $28.01. The company has a market cap of $1.115 billion and a P/E ratio of 161.54.
Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Monday, May 5th. The company reported $0.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.54 by $0.01. The company had revenue of $40.85 million for the quarter, compared to the consensus estimate of $35.75 million. During the same quarter last year, the company posted $0.47 earnings per share. Analysts expect that Sabra Health Care REIT will post $2.23 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Sabra Health Care REIT in a research note on Tuesday, June 10th. They now have a $28.00 price target on the stock, up previously from $25.00. Separately, analysts at Barclays initiated coverage on shares of Sabra Health Care REIT in a research note on Friday, June 6th. They set an “equal weight” rating and a $31.00 price target on the stock. Finally, analysts at Bank of America initiated coverage on shares of Sabra Health Care REIT in a research note on Monday, May 19th. They set a “neutral” rating and a $29.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. Sabra Health Care REIT has a consensus rating of “Hold” and a consensus price target of $31.00.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.